Document Detail


Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity.
MedLine Citation:
PMID:  21205027     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract.  Reuter SE, Evans AM (School of Pharmacy & Medical Sciences, University of South Australia, Adelaide, SA, Australia; Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia). Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. J Intern Med 2010; doi: 10.1111/j.1365-2796.2010.02341.x. Objective.  The underlying aetiology of chronic fatigue syndrome is currently unknown; however, in the light of carnitine's critical role in mitochondrial energy production, it has been suggested that chronic fatigue syndrome may be associated with altered carnitine homeostasis. This study was conducted to comparatively examine full endogenous carnitine profiles in patients with chronic fatigue syndrome and healthy controls. Design.  A cross-sectional, observational study. Setting and subjects.  Forty-four patients with chronic fatigue syndrome and 49 age- and gender-matched healthy controls were recruited from the community and studied at the School of Pharmacy & Medical Sciences, University of South Australia. Main outcome measures.  All participants completed a fatigue severity scale questionnaire and had a single fasting blood sample collected which was analysed for l-carnitine and 35 individual acylcarnitine concentrations in plasma by LC-MS/MS. Results.  Patients with chronic fatigue syndrome exhibited significantly altered concentrations of C8:1, C12DC, C14, C16:1, C18, C18:1, C18:2 and C18:1-OH acylcarnitines; of particular note, oleyl-l-carnitine (C18:1) and linoleyl-l-carnitine (C18:2) were, on average, 30-40% lower in patients than controls (P < 0.0001). Significant correlations between acylcarnitine concentrations and clinical symptomology were also demonstrated. Conclusions.  It is proposed that this disturbance in carnitine homeostasis is reflective of a reduction in carnitine palmitoyltransferase-I (CPT-I) activity, possibly a result of the accumulation of omega-6 fatty acids previously observed in this patient population. It is hypothesized that the administration of omega-3 fatty acids in combination with l-carnitine would increase CPT-I activity and improve chronic fatigue syndrome symptomology.
Authors:
S E Reuter; A M Evans
Related Documents :
18296897 - Acupuncture treatment for idiopathic horner's syndrome in a dog.
11239877 - Horner syndrome associated with implantation of a vagus nerve stimulator.
7211297 - Pulmonary embolic syndrome caused by cementing of hip endoprosthesis.
3177437 - The concurrence of klinefelter syndrome and fragile x syndrome.
17929077 - Multiple peripheral arterial and aortic aneurysms in behcet's syndrome: a case report.
9399347 - Prenatal sonographic findings in 187 fetuses with down syndrome.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-12-22
Journal Detail:
Title:  Journal of internal medicine     Volume:  -     ISSN:  1365-2796     ISO Abbreviation:  -     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2011-1-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8904841     Medline TA:  J Intern Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 The Association for the Publication of the Journal of Internal Medicine.
Affiliation:
From the School of Pharmacy & Medical Sciences Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
Next Document:  Cyanobacterial flavodoxin complements ferredoxin deficiency in knocked-down transgenic tobacco plant...